Sound velocity of CaSiO3 perovskite suggests the presence of basaltic crust in the Earth's lower mantle

…, T Irifune, Y Higo, Y Tange, T Arimoto, Z Liu, A Yamada - Nature, 2019 - nature.com
Laboratory measurements of sound velocities of high-pressure minerals provide crucial
information on the composition and constitution of the deep mantle via comparisons with …

Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis

A Yamada, Y Komaki, F Komaki, D Micic… - The Lancet …, 2018 - thelancet.com
Background The management and life expectancy of patients with cystic fibrosis have
improved substantially in the past three decades, which has resulted in an increased number of …

Characterization of biphenyl catabolic genes of gram-positive polychlorinated biphenyl degrader Rhodococcus sp. strain RHA1

E Masai, A Yamada, JM Healy, T Hatta… - Applied and …, 1995 - journals.asm.org
Rhodococcus sp. strain RHA1 is a gram-positive polychlorinated biphenyl (PCB) degrader
which can degrade 10 ppm of PCB48 (equivalent to Aroclor1248), including tri-, tetra-, and …

Development of Chemical Substances Regulating Biofilm Formation.

A Yamada, H Kitamura, K Yamaguchi… - Bulletin of the Chemical …, 1997 - jlc.jst.go.jp
The chemical substances which regulate biofilm formation were examined, and a bioassay
system which uses marine bacteria with adhering properties was developed. This bioassay …

The use of vedolizumab in preventing postoperative recurrence of Crohn's disease

A Yamada, Y Komaki, N Patel, F Komaki… - Inflammatory bowel …, 2018 - academic.oup.com
… images by the study investigators (Akihiro Yamada and Atsushi Sakuraba) when possible.
When the sites of anastomosis were not evaluated, patients were excluded from the analysis. …

Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis

Y Yoshimatsu, A Yamada, R Furukawa… - World Journal of …, 2015 - pmc.ncbi.nlm.nih.gov
AIM: To evaluate the effectiveness of probiotic therapy for suppressing relapse in patients
with inactive ulcerative colitis (UC). METHODS: Bio-Three tablets, each containing 2 mg of …

Risk of postoperative complications among inflammatory bowel disease patients treated preoperatively with vedolizumab

A Yamada, Y Komaki, N Patel, F Komaki… - Official journal of the …, 2017 - journals.lww.com
Objectives: Vedolizumab is increasingly used to treat patients with ulcerative colitis (UC) and
Crohn’s disease (CD), however, its safety during the perioperative period remains unclear. …

Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor

A Yamada, K Maeda, E Kamiyama, D Sugiyama… - Drug metabolism and …, 2007 - Elsevier
Olmesartan, a novel angiotensin II AT1-receptor antagonist, is excreted into both bile and
urine, with minimal metabolism. Because olmesartan is a hydrophilic anionic compound, some …

Systematic review with meta‐analysis: the efficacy and safety of CT‐P13, a biosimilar of anti‐tumour necrosis factor‐α agent (infliximab), in inflammatory bowel …

Y Komaki, A Yamada, F Komaki, D Micic… - Alimentary …, 2017 - Wiley Online Library
Background Biosimilars of anti‐tumour necrosis factor ( TNF )‐α agents have now become
clinically available for the treatment of inflammatory bowel diseases ( IBD ). Aim To perform a …

Polyglycolic acid sheet application to prevent esophageal stricture after endoscopic submucosal dissection for esophageal squamous cell carcinoma

T Iizuka, D Kikuchi, A Yamada, S Hoteya… - …, 2015 - thieme-connect.com
Background and study aim: Esophageal stricture following endoscopic submucosal
dissection (ESD) can be a serious complication in patients with large mucosal defects. This …